REPORT HIGHLIGHT The white biotechnology market is estimated to represent a global market of USD 238.9 billion by 2017 with the growth rate of 8.9%. Market Dynamics Industrial applications of biotechnology hold many promises for sustainable development. Branch of biotechnology that “uses living cells- from enzymes, yeast, plants, and bacteria to synthesize novel products that require less energy consumption, easily degradable and create less waste during production” is referred as White Biotechnology. Development of this industry is, at present, driven by the growing acceptance of new technology trends such as bioprocess modeling and metabolic modeling. Furthermore, growing awareness regarding environmental and functional benefits of using biofuel in developed and developing economies is predicted to be the major driver for the growth of white biotechnology market. In addition, factors such as growing demand for bioplastics, favourable government policies, constant research, and innovation to develop effective and high-quality API and cost reduction in production process augment the industry growth significantly. Regulatory authorities are continually striving to improve predictability and efficiency for the future products of biotechnology through their constant efforts. Governments in the U.S., China, Brazil, South East Asia, India, and European countries have implemented several favourable policies of tax reduction and fiscal incentives to promote the white biotechnology applications. For instance, the Executive Office of the President (EOP) introduced a memorandum, on July 2, 2017, directing the primary agencies that regulate the products of biotechnology to update the Coordinated Framework for the Regulation of Biotechnology. The agency is constantly engaged in developing a long-term strategy to ensure that the Federal biotechnology regulatory system is prepared to strengthen the future landscape of biotechnology products. Product Takeaway Based on products, the market is divided as Biomaterials, Biofuels, Industrial Enzymes, and Biochemical. Biofuels and biochemical are the largest revenue generating segment. In 2017, these segments have captured more than 70% revenue share of the worldwide white biotechnology industry revenue. Furthermore, the unstable price of conventional fuels such as natural gas, natural oil, and coal has created a prospective opportunity for these segments. Application Takeaway The industry finds wide applications in food & feed additive, bioenergy, pharmaceutical ingredients, personal care, and household products. Among which, bioenergy is expected to be the leading application as it eliminates the detrimental environmental effects of fossil-based fuel. Furthermore, the pharmaceutical industry extensively employs white biotechnology in order to develop antibodies, active pharmaceutical ingredients (API), and other complex biomolecules. This segment is anticipated to capture more than 20% revenue share of the global market throughout the study period. Regional Takeaway Regionally, North America accounted for the highest revenue share, i.e. 35.23% of the global market in 2017. Functional efficiency, environmental sustainability coupled with easy availability of raw materials are the key factors, stimulating the regional growth. On another hand, Asia Pacific has emerged as a major player in the white biotechnology market in the recent past along with North America and Europe. A large number of developing countries in the Asia Pacific (such as India, Thailand, Philippines, Colombia, Vietnam, etc.) have implemented the law of mandatory blending of biofuel in recent years. Furthermore, many Asia Pacific countries are aiming to increase the blending limit in the coming years. This would, in turn, is predicted to stimulate the demand for biofuel in the future, driving the overall industry growth. Key Vendor Takeaway Key players namely BioAmber, Amyris, BASF, Codexis, Evolva, Deinove, Novozymes, Metabolic Explorer, and Solazyme are profiled extensively. These companies are engaged in manufacturing a variety of biomaterials, biofuels, biochemicals and industrial enzymes. Industry rivalry among these players is high. Companies are aggressively investing in research and development activities to expand their product offering and production capabilities, thereby sustaining their market positions. For instance, Royal DSM opened its research and technology center for engineering plastics in Pune, India recently in April 2017. The company aims to support new product and application development through such expansion. The market size and forecast for each segment has been provided for the period 2014 to 2028, considering 2017 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2017 to 2028 for every reported segment. The years considered for the study are: Historical Year – 2014 & 2017 Base Year – 2017 Estimated Year – 2017 Projected Year – 2028 TARGET AUDIENCE Traders, Distributors, And Suppliers Manufacturers Hospitals Government and Regional Agencies and Research Organizations Consultants Distributors SCOPE OF THE REPORT The scope of this report covers the market by its major segments, which include as follows: MARKET, BY PRODUCT Biomaterials Biofuels Industrial Enzymes Biochemical MARKET, BY APPLICATION Food & Feed Additive Bioenergy Pharmaceutical Ingredients Personal Care Household Products MARKET, BY REGION North America U.S. Canada Europe Germany France Rest of Europe Asia Pacific India China Rest of APAC Rest of the World Middle East and Africa Latin America